1-4 of 4
Dominique Valteau-Couanet, MD
Close
Sort by
Journal Articles

Defibrotide (DF) for the Prevention of Hepatic Veno-Occlusive Disease (VOD) in Pediatric Stem Cell Transplantion: Results of a Prospective Phase II/III Randomized, Multicenter Study.

Selim Corbacioglu, MD, Simone Cesaro, MD, Maura Faraci, MD, Dominique Valteau-Couanet, MD, PhD, Bernd Gruhn, MD, Jaap Jan Boelens, MD, PhD, Cornelio Uderzo, MD, Netty Hewitt, Johanna Schrum, MD, Ingo Mueller, MD, Ansgar S Schulz, MD, Jerry Stein, MD, Robert Wynn, MRCP, FRCPath, MD, Johann Greil, MD, Susanne Matthes, MD, Sykora Karl-Walter, MD, Monika Fuehrer, MD, Anne O'Meare, MD, Klaus-Michael Debatin, MD, Joseph Massaro, PhD, Ralph D'Agostino, PhD, Margeret Hoyle, Massimo Iacobelli, MD, Christina Peters, MD, Giorgio Dini, MD
Journal: Blood
Blood (2009) 114 (22): 653.
https://doi.org/10.1182/blood.V114.22.653.653
Published: 2009
Journal Articles

Ancestim (r-metHuSCF) Plus Filgrastim for the Mobilization and Collection of Peripheral Blood Progenitor Cells for Autologous Transplant after Failure of Prior Mobilization: The French Experience of Compassionate Use.

Valerie Lapierre, MD, PhD, Christian Chabannon, MD, Caroline Makowski, MD, Cecile Dumesnil, MD, Dominique Valteau-Couanet, MD, PhD, Anne Vekhoff, MD, Denis Caillot, MD, Nabih Azar, MD, Marine Divine, MD, Karin Blakolmer, MD, Christian Cailliot, MD, Philippe Moreau, MD, PhD, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3281.
https://doi.org/10.1182/blood.V110.11.3281.3281
Published: 2007
Journal Articles

A New IV Busulfan Fixed Dosing as Part of BuMel or BuCy Conditioning Regimens: A Pharmacokinetic/Pharmacodynamic Study in Pediatric Patients Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Gilles Vassal, MD, PhD, Hélène Esperou, MD, Dominique Valteau-Couanet, MD, Jean Claude Gentet, MD, François Doz, MD, Françoise Méchinaud, MD, Claire Galambrun, MD, Alain Fischer, MD, Hamadi Zouabi, MD, Laurent Nguyen, Pharm D, Gérard Michel, MD
Journal: Blood
Blood (2005) 106 (11): 5200.
https://doi.org/10.1182/blood.V106.11.5200.5200
Published: 2005
Journal Articles

A New Busulfan Fixed Dosing for Conditioning before Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children with Malignant and Non-Malignant Diseases: Pharmacokinetics, Toxicity and Clinical Outcomes.

Gérard Michel, MD, Dominique Valteau-Couanet, MD, Hélène Esperou, MD, Jean Claude Gentet, MD, François Doz, MD, Françoise Méchinaud, MD, Claire Galambrun, MD, Alain Fischer, MD, Hamadi Zouabi, MD, Christian Puozzo, PhD, Gilles Vassal, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1758.
https://doi.org/10.1182/blood.V106.11.1758.1758
Published: 2005